A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Had Record Revenues in 2021 of $13.6 Million, Up 81% Over 2020

AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) Had Record Revenues in 2021 of $13.6 Million, Up 81% Over 2020

posted on Mar 15, 2022 12:19PM

Share
New Message
Please login to post a reply